These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 8159650)

  • 21. Large cell dysplasia of hepatocytes, is it a premalignant condition?
    Kovács L; Elek G
    Acta Morphol Hung; 1987; 35(1-2):47-57. PubMed ID: 3124508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
    Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
    Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. alpha 1-Antitrypsin deficiency and hepatocellular carcinoma. Association with cirrhosis, copper storage, and Mallory bodies.
    Rubel LR; Ishak KG; Benjamin SB; Knuff TE
    Arch Pathol Lab Med; 1982 Dec; 106(13):678-81. PubMed ID: 6291490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphologic approach to hepatocellular carcinoma development in man: de novo or the so-called 'dysplastic nodule-carcinoma' sequence?
    Taguchi K; Asayama Y; Aishima S; Nishi H; Sugimachi K; Matsuura S; Terashi T; Yamanaka T; Shimada M; Sugimachi K; Tsuneyoshi M
    Oncol Rep; 2002; 9(4):737-43. PubMed ID: 12066201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical study of the appearance of some markers in liver adjoining hepatocellular carcinoma.
    Cantaboni A; Sironi M; Taccagni GL; Ferrari AM
    Basic Appl Histochem; 1986; 30(2):165-72. PubMed ID: 2427060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship.
    Nzeako UC; Goodman ZD; Ishak KG
    Am J Gastroenterol; 1996 May; 91(5):879-84. PubMed ID: 8633575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
    Paiva C; Oshima CT; Lanzoni VP; Forones NM
    Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver cell dysplasia: a premalignant condition.
    Anthony PP; Vogel CL; Barker LF
    J Clin Pathol; 1973 Mar; 26(3):217-23. PubMed ID: 4700503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preneoplastic lesions in chronic hepatitis C.
    Thung SN; Hytiroglou P; Fiel I; Theise N
    Princess Takamatsu Symp; 1995; 25():171-8. PubMed ID: 8875622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Liver changes suggesting alpha-1-antitrypsin deficiency (a neglected disease)].
    Bartók I; Korányi G; Bartók K; Nádor K; Hegedüs C
    Orv Hetil; 1989 Sep; 130(36):1911-6, 1919. PubMed ID: 2674844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preneoplastic conditions of the liver.
    Riegler JL
    Semin Gastrointest Dis; 1996 Apr; 7(2):74-87. PubMed ID: 8705261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological precursors of hepatocellular carcinoma: a morphometrical analysis.
    Giannini A; Zampi G; Bartoloni F; Omer S
    Hepatogastroenterology; 1987 Jun; 34(3):95-7. PubMed ID: 3038718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of interferon alpha/beta receptor in human hepatocellular carcinoma.
    Kondo M; Nagano H; Sakon M; Yamamoto H; Morimoto O; Arai I; Miyamoto A; Eguchi H; Dono K; Nakamori S; Umeshita K; Wakasa K; Ohmoto Y; Monden M
    Int J Oncol; 2000 Jul; 17(1):83-8. PubMed ID: 10853022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
    van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE
    Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alpha-1-antitrypsin deficiency and liver diseases].
    Bartók K; Korányi G; Bartók K; Nádor K; Hegedũs C
    Morphol Igazsagugyi Orv Sz; 1989 Oct; 29(4):249-54. PubMed ID: 2594021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver cell dysplasia and hepatocellular carcinoma: a histological and immunohistochemical study.
    Roncalli M; Borzio M; de Biagi G; Servida E; Cantaboni A; Sironi M; Taccagni GL
    Histopathology; 1985 Feb; 9(2):209-21. PubMed ID: 2985489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatic cell dysplasia. A pre-malignant lesion related to hepatocellular carcinoma and infection by hepatitis B virus].
    de Queiroz AC; Moreira DE; Andrade ML
    Arq Gastroenterol; 1987; 24(2):80-3. PubMed ID: 2849924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.